Sexually Transmitted Diseases Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Description
Growth Factors of sexually transmitted diseases (STD) testing Market
The global sexually transmitted diseases (STD) testing market is witnessing strong growth due to rising infection rates, increasing awareness of sexual health, and expanding government-led screening initiatives. According to Fortunes Business Insights, the market was valued at USD 11.07 billion in 2025 and is projected to grow from USD 11.97 billion in 2026 to USD 23.95 billion by 2034, registering a CAGR of 9.10% during the forecast period (2026–2034).
North America dominated the global market in 2025, accounting for 42.80% market share, supported by robust healthcare infrastructure, public-private partnerships, and strong government initiatives to enhance disease detection.
Market Dynamics
Rising Incidence of STDs Driving Market Growth
Sexually transmitted diseases are caused by bacteria, viruses, or parasites and are transmitted through sexual contact or vertically from mother to child. Many STDs are asymptomatic, making timely and accurate diagnosis critical to limit further transmission.
According to global estimates:
38.4 million people were living with HIV in 2021
491 million people aged 15–49 had HSV-2 infection worldwide
High incidence rates of chlamydia, gonorrhea, syphilis, and HIV continue to increase demand for testing kits and diagnostic instruments
Increasing risky sexual behavior, lack of consistent condom usage, and limited sexual health education in certain populations are further contributing to the growing disease burden.
Market Trends
Shift from Laboratory Testing to Point-of-Care Testing
One of the most notable trends in the STD testing market is the gradual shift from laboratory-based testing to point-of-care testing (POCT). While laboratory testing dominated the market in 2026 with a share of 78.33%, POCT is expected to grow at the highest CAGR during the forecast period.
Point-of-care tests offer:
Faster turnaround time
Lower testing costs
Improved accessibility
Reduced stigma and confidentiality concerns
These benefits are encouraging healthcare providers and patients to adopt POCT solutions across hospitals, clinics, pharmacies, and homecare settings.
Segmentation Analysis
By Product Type
Reagents & kits dominated the market in 2026, holding 79.32% share, driven by high testing volumes and recurring demand.
Instruments are expected to grow steadily due to rising sample throughput in diagnostic laboratories.
By Application
Chlamydia testing led the market in 2026 with a 24.47% share, owing to its high prevalence and frequent testing requirements.
Gonorrhea, HIV, and HPV also accounted for significant market shares.
Syphilis and genital herpes held comparatively lower shares due to limited routine screening.
By End User
Diagnostic centers dominated the market in 2026 with 52.34% share, supported by faster service delivery and advanced diagnostic capabilities.
Hospitals & clinics followed, especially in emerging economies.
Home-based testing is gaining traction due to privacy and convenience benefits.
Regional Insights
North America: Market valued at USD 4.74 billion in 2025; strong growth driven by public-private partnerships and awareness programs.
Europe: Growth supported by advanced diagnostic infrastructure and digital result delivery systems.
Asia Pacific: Expected to grow at the highest CAGR, supported by government initiatives and rising awareness in countries such as Japan, China, and India.
Latin America & Middle East & Africa: Moderate growth due to increasing government and NGO-led awareness programs.
Competitive Landscape
The global STD testing market is fragmented, with major players including:
Abbott
F. Hoffmann-La Roche Ltd
bioMérieux
Bio-Rad Laboratories
Thermo Fisher Scientific
BD
Hologic, Inc.
These companies are focusing on R&D investments, strategic collaborations, and product launches to expand their global presence.
Conclusion
The global sexually transmitted diseases testing market is set for strong expansion from 2026 to 2034, driven by rising disease prevalence, growing awareness, and increasing adoption of point-of-care testing solutions. With the market expected to reach USD 23.95 billion by 2034, continued government initiatives, technological advancements, and improved accessibility to testing will play a crucial role in shaping market growth. Despite challenges such as stigma and reluctance toward testing, sustained efforts by healthcare authorities and industry players are expected to significantly strengthen STD detection and prevention worldwide.
ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 9.10% from 2026 to 2034
Unit Value (USD billion)
Segmentation By Product Type, Application, Setting, End User, and Region
By Product Type Instruments
Reagents & Kits
By Application Chlamydia
Syphilis
Genital Herpes
Gonorrhea
Human Immunodeficiency Virus
Human Papillomavirus
Others
By Setting Laboratory Testing
Point-of-Care
By End User Hospital & Clinics
Diagnostic Centers
Others
By Region North America (By Product Type, By Application, By Setting, By End User, By Country)
Please Note: It will take 2-3 business days to complete the report upon order confirmation.
The global sexually transmitted diseases (STD) testing market is witnessing strong growth due to rising infection rates, increasing awareness of sexual health, and expanding government-led screening initiatives. According to Fortunes Business Insights, the market was valued at USD 11.07 billion in 2025 and is projected to grow from USD 11.97 billion in 2026 to USD 23.95 billion by 2034, registering a CAGR of 9.10% during the forecast period (2026–2034).
North America dominated the global market in 2025, accounting for 42.80% market share, supported by robust healthcare infrastructure, public-private partnerships, and strong government initiatives to enhance disease detection.
Market Dynamics
Rising Incidence of STDs Driving Market Growth
Sexually transmitted diseases are caused by bacteria, viruses, or parasites and are transmitted through sexual contact or vertically from mother to child. Many STDs are asymptomatic, making timely and accurate diagnosis critical to limit further transmission.
According to global estimates:
38.4 million people were living with HIV in 2021
491 million people aged 15–49 had HSV-2 infection worldwide
High incidence rates of chlamydia, gonorrhea, syphilis, and HIV continue to increase demand for testing kits and diagnostic instruments
Increasing risky sexual behavior, lack of consistent condom usage, and limited sexual health education in certain populations are further contributing to the growing disease burden.
Market Trends
Shift from Laboratory Testing to Point-of-Care Testing
One of the most notable trends in the STD testing market is the gradual shift from laboratory-based testing to point-of-care testing (POCT). While laboratory testing dominated the market in 2026 with a share of 78.33%, POCT is expected to grow at the highest CAGR during the forecast period.
Point-of-care tests offer:
Faster turnaround time
Lower testing costs
Improved accessibility
Reduced stigma and confidentiality concerns
These benefits are encouraging healthcare providers and patients to adopt POCT solutions across hospitals, clinics, pharmacies, and homecare settings.
Segmentation Analysis
By Product Type
Reagents & kits dominated the market in 2026, holding 79.32% share, driven by high testing volumes and recurring demand.
Instruments are expected to grow steadily due to rising sample throughput in diagnostic laboratories.
By Application
Chlamydia testing led the market in 2026 with a 24.47% share, owing to its high prevalence and frequent testing requirements.
Gonorrhea, HIV, and HPV also accounted for significant market shares.
Syphilis and genital herpes held comparatively lower shares due to limited routine screening.
By End User
Diagnostic centers dominated the market in 2026 with 52.34% share, supported by faster service delivery and advanced diagnostic capabilities.
Hospitals & clinics followed, especially in emerging economies.
Home-based testing is gaining traction due to privacy and convenience benefits.
Regional Insights
North America: Market valued at USD 4.74 billion in 2025; strong growth driven by public-private partnerships and awareness programs.
Europe: Growth supported by advanced diagnostic infrastructure and digital result delivery systems.
Asia Pacific: Expected to grow at the highest CAGR, supported by government initiatives and rising awareness in countries such as Japan, China, and India.
Latin America & Middle East & Africa: Moderate growth due to increasing government and NGO-led awareness programs.
Competitive Landscape
The global STD testing market is fragmented, with major players including:
Abbott
F. Hoffmann-La Roche Ltd
bioMérieux
Bio-Rad Laboratories
Thermo Fisher Scientific
BD
Hologic, Inc.
These companies are focusing on R&D investments, strategic collaborations, and product launches to expand their global presence.
Conclusion
The global sexually transmitted diseases testing market is set for strong expansion from 2026 to 2034, driven by rising disease prevalence, growing awareness, and increasing adoption of point-of-care testing solutions. With the market expected to reach USD 23.95 billion by 2034, continued government initiatives, technological advancements, and improved accessibility to testing will play a crucial role in shaping market growth. Despite challenges such as stigma and reluctance toward testing, sustained efforts by healthcare authorities and industry players are expected to significantly strengthen STD detection and prevention worldwide.
ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 9.10% from 2026 to 2034
Unit Value (USD billion)
Segmentation By Product Type, Application, Setting, End User, and Region
By Product Type Instruments
Reagents & Kits
By Application Chlamydia
Syphilis
Genital Herpes
Gonorrhea
Human Immunodeficiency Virus
Human Papillomavirus
Others
By Setting Laboratory Testing
Point-of-Care
By End User Hospital & Clinics
Diagnostic Centers
Others
By Region North America (By Product Type, By Application, By Setting, By End User, By Country)
- U.S.
- Canada
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Brazil
- Mexico
- Rest of Latin America
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Please Note: It will take 2-3 business days to complete the report upon order confirmation.
Table of Contents
162 Pages
- 1. Introduction
- 1.1. Market Scope
- 1.2. Market Segmentation
- 1.3. Market Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Number of Dentists – Key Countries
- 4.2. Dental Expenditure – Key Countries
- 4.3. Key Industry Developments – Mergers, Acquisitions, Partnerships, etc.
- 4.4. Technological Advancement in Dental Imaging
- 4.5. Impact of COVID-19 on the Market
- 5. Global Dental Imaging Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast – By Type
- 5.1.1. Extraoral Imaging
- 5.1.1.1. Panoramic Systems
- 5.1.1.2. Panoramic & Cephalometric Systems
- 5.1.1.3. Dental Cone Beam Computed Tomography (CBCT)
- 5.1.2. Intraoral Imaging
- 5.1.2.1. X-ray Systems
- 5.1.2.2. Intraoral Sensors
- 5.1.2.3. Intraoral Photostimulable Phosphor Systems
- 5.1.2.4. Intraoral Cameras
- 5.1.2.5. Intraoral Scanners
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Endodontics
- 5.2.2. Implantology
- 5.2.3. Orthodontics
- 5.2.4. Oral & Maxillofacial Surgery
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast – By End-user
- 5.3.1. Solo Practices
- 5.3.2. DSO/Group Practices
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Dental Imaging Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast – By Type
- 6.1.1. Extraoral Imaging
- 6.1.1.1. Panoramic Systems
- 6.1.1.2. Panoramic & Cephalometric Systems
- 6.1.1.3. Dental Cone Beam Computed Tomography (CBCT)
- 6.1.2. Intraoral Imaging
- 7. 6.1.2.1.X-ray Systems
- 8. 6.1.2.2. Intraoral Sensors
- 9. 6.1.2.3. Intraoral Photostimulable Phosphor Systems
- 10. 6.1.2.4. Intraoral Cameras
- 11. 6.1.2.5. Intraoral Scanners
- 11.1. Market Analysis, Insights and Forecast – By Application
- 11.1.1. Endodontics
- 11.1.2. Implantology
- 11.1.3. Orthodontics
- 11.1.4. Oral & Maxillofacial Surgery
- 11.1.5. Others
- 11.2. Market Analysis, Insights and Forecast – By End-user
- 11.2.1. Solo Practices
- 11.2.2. DSO/Group Practices
- 11.2.3. Others
- 11.3. Market Analysis, Insights and Forecast – By Country
- 11.3.1. U.S.
- 11.3.1.1. By Type
- 11.3.2. Canada
- 11.3.2.1. By Type
- 12. Europe Dental Imaging Market Analysis, Insights and Forecast, 2021-2034
- 12.1. Market Analysis, Insights and Forecast – By Type
- 12.1.1. Extraoral Imaging
- 12.1.1.1. Panoramic Systems
- 12.1.1.2. Panoramic & Cephalometric Systems
- 12.1.1.3. Dental Cone Beam Computed Tomography (CBCT)
- 12.1.2. Intraoral Imaging
- 12.1.2.1. X-ray Systems
- 12.1.2.2. Intraoral Sensors
- 12.1.2.3. Intraoral Photostimulable Phosphor Systems
- 12.1.2.4. Intraoral Cameras
- 12.1.2.5. Intraoral Scanners
- 12.2. Market Analysis, Insights and Forecast – By Application
- 12.2.1. Endodontics
- 12.2.2. Implantology
- 12.2.3. Orthodontics
- 12.2.4. Oral & Maxillofacial Surgery
- 12.2.5. Others
- 12.3. Market Analysis, Insights and Forecast – By End-user
- 12.3.1. Solo Practices
- 12.3.2. DSO/Group Practices
- 12.3.3. Others
- 12.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 12.4.1. Germany
- 12.4.1.1. By Type
- 12.4.2. U.K.
- 12.4.2.1. By Type
- 12.4.3. France
- 12.4.3.1. By Type
- 12.4.4. Spain
- 12.4.4.1. By Type
- 12.4.5. Italy
- 12.4.5.1. By Type
- 12.4.6. Scandinavia
- 12.4.6.1. By Type
- 12.4.7. Rest of Europe
- 12.4.7.1. By Type
- 13. Asia Pacific Dental Imaging Market Analysis, Insights and Forecast, 2021-2034
- 13.1. Market Analysis, Insights and Forecast – By Type
- 13.1.1. Extraoral Imaging
- 13.1.1.1. Panoramic Systems
- 13.1.1.2. Panoramic & Cephalometric Systems
- 13.1.1.3. Dental Cone Beam Computed Tomography (CBCT)
- 13.1.2. Intraoral Imaging
- 13.1.2.1. X-ray Systems
- 13.1.2.2. Intraoral Sensors
- 13.1.2.3. Intraoral Photostimulable Phosphor Systems
- 13.1.2.4. Intraoral Cameras
- 13.1.2.5. Intraoral Scanners
- 13.2. Market Analysis, Insights and Forecast – By Application
- 13.2.1. Endodontics
- 13.2.2. Implantology
- 13.2.3. Orthodontics
- 13.2.4. Oral & Maxillofacial Surgery
- 13.2.5. Others
- 13.3. Market Analysis, Insights and Forecast – By End-user
- 13.3.1. Solo Practices
- 13.3.2. DSO/Group Practices
- 13.3.3. Others
- 13.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 13.4.1. Japan
- 13.4.1.1. By Type
- 13.4.2. China
- 13.4.2.1. By Type
- 13.4.3. India
- 13.4.3.1. By Type
- 13.4.4. Australia
- 13.4.4.1. By Type
- 13.4.5. Southeast Asia
- 13.4.5.1. By Type
- 13.4.6. South Korea
- 13.4.6.1. By Type
- 13.4.7. Rest of Asia Pacific
- 13.4.7.1. By Type
- 14. Latin America Dental Imaging Market Analysis, Insights and Forecast, 2021-2034
- 14.1. Market Analysis, Insights and Forecast – By Type
- 14.1.1. Extraoral Imaging
- 14.1.1.1. Panoramic Systems
- 14.1.1.2. Panoramic & Cephalometric Systems
- 14.1.1.3. Dental Cone Beam Computed Tomography (CBCT)
- 14.1.2. Intraoral Imaging
- 14.1.2.1. X-ray Systems
- 14.1.2.2. Intraoral Sensors
- 14.1.2.3. Intraoral Photostimulable Phosphor Systems
- 14.1.2.4. Intraoral Cameras
- 14.1.2.5. Intraoral Scanners
- 14.2. Market Analysis, Insights and Forecast – By Application
- 14.2.1. Endodontics
- 14.2.2. Implantology
- 14.2.3. Orthodontics
- 14.2.4. Oral & Maxillofacial Surgery
- 14.2.5. Others
- 14.3. Market Analysis, Insights and Forecast – By End-user
- 14.3.1. Solo Practices
- 14.3.2. DSO/Group Practices
- 14.3.3. Others
- 14.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 14.4.1. Brazil
- 14.4.1.1. By Type
- 14.4.2. Mexico
- 14.4.2.1. By Type
- 14.4.3. Rest of Latin America
- 14.4.3.1. By Type
- 15. Middle East & Africa Dental Imaging Market Analysis, Insights and Forecast, 2021-2034
- 15.1. Market Analysis, Insights and Forecast – By Type
- 15.1.1. Extraoral Imaging
- 15.1.1.1. Panoramic Systems
- 15.1.1.2. Panoramic & Cephalometric Systems
- 15.1.1.3. Dental Cone Beam Computed Tomography (CBCT)
- 15.1.2. Intraoral Imaging
- 15.1.2.1. X-ray Systems
- 15.1.2.2. Intraoral Sensors
- 15.1.2.3. Intraoral Photostimulable Phosphor Systems
- 15.1.2.4. Intraoral Cameras
- 15.1.2.5. Intraoral Scanners
- 15.2. Market Analysis, Insights and Forecast – By Application
- 15.2.1. Endodontics
- 15.2.2. Implantology
- 15.2.3. Orthodontics
- 15.2.4. Oral & Maxillofacial Surgery
- 15.2.5. Others
- 15.3. Market Analysis, Insights and Forecast – By End-user
- 15.3.1. Solo Practices
- 15.3.2. DSO/Group Practices
- 15.3.3. Others
- 15.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 15.4.1. GCC
- 15.4.1.1. By Type
- 15.4.2. South Africa
- 15.4.2.1. By Type
- 15.4.3. Rest of Middle East & Africa
- 15.4.3.1. By Type
- 16. Comparative Analysis
- 16.1. Global Market Share Analysis (2025)
- 16.2. Company Profiles
- 16.2.1. Acteon
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Strategies
- 16.2.1.6. Financials (Based on Availability)
- 16.2.2. Dentsply Sirona
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Strategies
- 16.2.2.6. Financials (Based on Availability)
- 16.2.3. OMNIVISION
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Strategies
- 16.2.3.6. Financials (Based on Availability)
- 16.2.4. Align Technology, Inc.
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Strategies
- 16.2.4.6. Financials (Based on Availability)
- 16.2.5. Medit
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Strategies
- 16.2.5.6. Financials (Based on Availability)
- 16.2.6. PLANMECA OY
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Strategies
- 16.2.6.6. Financials (Based on Availability)
- 16.2.7. Trident
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Strategies
- 16.2.7.6. Financials (Based on Availability)
- 16.2.8. Owandy Radiology
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Strategies
- 16.2.8.6. Financials (Based on Availability)
- 16.2.9. XpectVision Technology Co., Ltd
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Strategies
- 16.2.9.6. Financials (Based on Availability)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



